vs
Acadia Healthcare Company, Inc.(ACHC)与Toast, Inc.(TOST)财务数据对比。点击上方公司名可切换其他公司
Toast, Inc.的季度营收约是Acadia Healthcare Company, Inc.的2.0倍($1.6B vs $821.5M),Toast, Inc.净利率更高(6.2% vs -143.3%,领先149.5%),Toast, Inc.同比增速更快(22.0% vs 6.1%),Toast, Inc.自由现金流更多($178.0M vs $-179.5M),过去两年Toast, Inc.的营收复合增速更高(23.3% vs 3.4%)
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商,目前在美国及波多黎各地区运营着超过225家医疗机构,搭建了覆盖广泛的行为健康服务网络,为有相关需求的人群提供专业的心理健康与行为干预服务。
Toast, Inc.是总部位于美国马萨诸塞州波士顿的云餐饮管理软件企业,主打基于安卓操作系统研发的一体化销售点(POS)系统,可为餐饮商家提供涵盖收银、订单管理等在内的全场景门店经营解决方案。
ACHC vs TOST — 直观对比
营收规模更大
TOST
是对方的2.0倍
$821.5M
营收增速更快
TOST
高出15.9%
6.1%
净利率更高
TOST
高出149.5%
-143.3%
自由现金流更多
TOST
多$357.5M
$-179.5M
两年增速更快
TOST
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $821.5M | $1.6B |
| 净利润 | $-1.2B | $101.0M |
| 毛利率 | — | 25.9% |
| 营业利润率 | -142.4% | 5.2% |
| 净利率 | -143.3% | 6.2% |
| 营收同比 | 6.1% | 22.0% |
| 净利润同比 | -3710.4% | 215.6% |
| 每股收益(稀释后) | $-12.98 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACHC
TOST
| Q4 25 | $821.5M | $1.6B | ||
| Q3 25 | $851.6M | $1.6B | ||
| Q2 25 | $869.2M | $1.6B | ||
| Q1 25 | $770.5M | $1.3B | ||
| Q4 24 | $774.2M | $1.3B | ||
| Q3 24 | $815.6M | $1.3B | ||
| Q2 24 | $796.0M | $1.2B | ||
| Q1 24 | $768.1M | $1.1B |
净利润
ACHC
TOST
| Q4 25 | $-1.2B | $101.0M | ||
| Q3 25 | $36.2M | $105.0M | ||
| Q2 25 | $30.1M | $80.0M | ||
| Q1 25 | $8.4M | $56.0M | ||
| Q4 24 | $32.6M | $32.0M | ||
| Q3 24 | $68.1M | $56.0M | ||
| Q2 24 | $78.5M | $14.0M | ||
| Q1 24 | $76.4M | $-83.0M |
毛利率
ACHC
TOST
| Q4 25 | — | 25.9% | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | 25.3% | ||
| Q1 25 | — | 25.9% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 24.7% | ||
| Q2 24 | — | 23.0% | ||
| Q1 24 | — | 23.2% |
营业利润率
ACHC
TOST
| Q4 25 | -142.4% | 5.2% | ||
| Q3 25 | 4.7% | 5.1% | ||
| Q2 25 | 5.8% | 5.2% | ||
| Q1 25 | 1.7% | 3.2% | ||
| Q4 24 | 4.9% | 2.5% | ||
| Q3 24 | 12.1% | 2.6% | ||
| Q2 24 | 13.4% | 0.4% | ||
| Q1 24 | 12.9% | -5.2% |
净利率
ACHC
TOST
| Q4 25 | -143.3% | 6.2% | ||
| Q3 25 | 4.3% | 6.4% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 1.1% | 4.2% | ||
| Q4 24 | 4.2% | 2.4% | ||
| Q3 24 | 8.4% | 4.3% | ||
| Q2 24 | 9.9% | 1.1% | ||
| Q1 24 | 9.9% | -7.7% |
每股收益(稀释后)
ACHC
TOST
| Q4 25 | $-12.98 | $0.18 | ||
| Q3 25 | $0.40 | $0.16 | ||
| Q2 25 | $0.33 | $0.13 | ||
| Q1 25 | $0.09 | $0.09 | ||
| Q4 24 | $0.36 | $0.09 | ||
| Q3 24 | $0.74 | $0.07 | ||
| Q2 24 | $0.85 | $0.02 | ||
| Q1 24 | $0.83 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $1.4B |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $2.1B |
| 总资产 | $5.5B | $3.1B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACHC
TOST
| Q4 25 | $133.2M | $1.4B | ||
| Q3 25 | $118.7M | $1.4B | ||
| Q2 25 | $131.4M | $1.2B | ||
| Q1 25 | $91.2M | $1.0B | ||
| Q4 24 | $76.3M | $903.0M | ||
| Q3 24 | $82.1M | $761.0M | ||
| Q2 24 | $77.2M | $691.0M | ||
| Q1 24 | $77.3M | $578.0M |
总债务
ACHC
TOST
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
股东权益
ACHC
TOST
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $1.8B | ||
| Q1 25 | $3.0B | $1.7B | ||
| Q4 24 | $3.1B | $1.5B | ||
| Q3 24 | $3.0B | $1.4B | ||
| Q2 24 | $3.0B | $1.3B | ||
| Q1 24 | $2.9B | $1.2B |
总资产
ACHC
TOST
| Q4 25 | $5.5B | $3.1B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.3B | $2.8B | ||
| Q1 25 | $6.1B | $2.6B | ||
| Q4 24 | $6.0B | $2.4B | ||
| Q3 24 | $5.9B | $2.2B | ||
| Q2 24 | $5.7B | $2.2B | ||
| Q1 24 | $5.5B | $2.1B |
负债/权益比
ACHC
TOST
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $194.0M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $178.0M |
| 自由现金流率自由现金流/营收 | -21.8% | 10.9% |
| 资本支出强度资本支出/营收 | 11.3% | 1.0% |
| 现金转化率经营现金流/净利润 | — | 1.92× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $608.0M |
8季度趋势,按日历期对齐
经营现金流
ACHC
TOST
| Q4 25 | $-86.3M | $194.0M | ||
| Q3 25 | $73.2M | $165.0M | ||
| Q2 25 | $133.5M | $223.0M | ||
| Q1 25 | $11.5M | $79.0M | ||
| Q4 24 | $116.7M | $147.0M | ||
| Q3 24 | $163.1M | $109.0M | ||
| Q2 24 | $171.1M | $124.0M | ||
| Q1 24 | $-321.3M | $-20.0M |
自由现金流
ACHC
TOST
| Q4 25 | $-179.5M | $178.0M | ||
| Q3 25 | $-63.0M | $153.0M | ||
| Q2 25 | $-34.2M | $208.0M | ||
| Q1 25 | $-163.2M | $69.0M | ||
| Q4 24 | $-86.8M | $134.0M | ||
| Q3 24 | $-27.1M | $97.0M | ||
| Q2 24 | $16.9M | $108.0M | ||
| Q1 24 | $-463.7M | $-33.0M |
自由现金流率
ACHC
TOST
| Q4 25 | -21.8% | 10.9% | ||
| Q3 25 | -7.4% | 9.4% | ||
| Q2 25 | -3.9% | 13.4% | ||
| Q1 25 | -21.2% | 5.2% | ||
| Q4 24 | -11.2% | 10.0% | ||
| Q3 24 | -3.3% | 7.4% | ||
| Q2 24 | 2.1% | 8.7% | ||
| Q1 24 | -60.4% | -3.1% |
资本支出强度
ACHC
TOST
| Q4 25 | 11.3% | 1.0% | ||
| Q3 25 | 16.0% | 0.7% | ||
| Q2 25 | 19.3% | 1.0% | ||
| Q1 25 | 22.7% | 0.7% | ||
| Q4 24 | 26.3% | 1.0% | ||
| Q3 24 | 23.3% | 0.9% | ||
| Q2 24 | 19.4% | 1.3% | ||
| Q1 24 | 18.5% | 1.2% |
现金转化率
ACHC
TOST
| Q4 25 | — | 1.92× | ||
| Q3 25 | 2.02× | 1.57× | ||
| Q2 25 | 4.43× | 2.79× | ||
| Q1 25 | 1.37× | 1.41× | ||
| Q4 24 | 3.58× | 4.59× | ||
| Q3 24 | 2.39× | 1.95× | ||
| Q2 24 | 2.18× | 8.86× | ||
| Q1 24 | -4.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
TOST
| Technology Service | $1.3B | 82% |
| License | $256.0M | 16% |
| Product And Professional Services | $43.0M | 3% |